Global Anti-Venom Market Insights, Forecast to 2025

Global Anti-Venom market is anticipated to grow at a CAGR of XX% by 2023, according to a new report published by Marketintelligencedata Inc. The report segments the market and forecasts its size, by volume and value, on the basis of application, by products, and by geography (North America, Europe, Asia-Pacific, MEA and South America).

The Global Market for Anti-Venom to 2023 offers detailed coverage of guanidine Anti-Venom industry and presents main market trends. The market research gives historical and forecast market size, demand and production forecasts, end-use demand details, price trends, and company shares of the leading Anti-Venom producers to provide exhaustive coverage of the guanidine carbonate.

This research report includes following contents:

  • Anti-Venom Product details, including pictures and technical specifications
  • Anti-Venom manufacturers, distributors and channels
  • Major players present in the Anti-Venom
  • Information on competitor market shares, revenue, unit sales etc
  • Breakdown by applications for the Market
  • Value chain and distributor details in the market

Key vendors:

  • Medtoxin Venom Laboratories
  • Institute of Immunology
  • Alomone Labs
  • Sigma Aldrich
  • Wyeth Pharmaceuticals
  • Protherics PLC
  • Bharat Serums and Vaccines
  • Butantan Institute
  • Haffkine Bio-Pharmaceutical Corporation
  • Micropaharm Limited
  • Market size by Product
  • Cytotoxic
  • Neurotoxic
  • Haemotoxic
  • Cardiotoxic
  • Myotoxic
  • Market size by End User
  • Snake
  • Spider
  • Scorpion
  • Market size by Region
  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Singapore
  • Malaysia
  • Philippines
  • Thailand
  • Vietnam
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Central & South America
  • Brazil
  • Rest of Central & South America
  • Middle East & Africa
  • GCC Countries
  • Turkey
  • Egypt
  • South Africa
  • The study objectives of this report are:
  • To study and analyze the global Anti-Venom market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
  • To understand the structure of Anti-Venom market by identifying its various subsegments.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • Focuses on the key global Anti-Venom companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
  • To project the value and sales volume of Anti-Venom submarkets, with respect to key regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • In this study, the years considered to estimate the market size of Anti-Venom are as follows:
  • History Year: 2014-2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025
  • This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anti-Venom market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
  • For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key regions:

North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Malaysia, Philippines, Thailand, Vietnam, Europe, Germany, France, UK, Italy, Spain, Russia, Central & South America, Brazil, Rest of Central & South America, Middle East & Africa, GCC Countries, Turkey, Egypt, South Africa

Additionally, the market is segmented by the following sectors

  • Cytotoxic
  • Neurotoxic
  • Haemotoxic
  • Cardiotoxic
  • Myotoxic

Not only this, figures covering the end user applications are also provided according to the following classification

  • Snake
  • Spider
  • Scorpion

In summary, the report serves to study and analyse the Anti-Venom size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anti-Venom, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

Overall the report is an excellent source for managers, researches and top executives alike to analyse and get clarity on the market standings and business forecast. We provide the information after thorough research and analysis saving precious hours and budget for the companies. We have been serving major clients like Sony, BCG, PWC, Mck, Hewlett Packard, Technicolor Etc.

  • 1 Study Coverage
    • 1.1 Anti-Venom Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Anti-Venom Market Size Growth Rate by Product
      • 1.4.2 Cytotoxic
      • 1.4.3 Neurotoxic
      • 1.4.4 Haemotoxic
      • 1.4.5 Cardiotoxic
      • 1.4.6 Myotoxic
    • 1.5 Market by End User
      • 1.5.1 Global Anti-Venom Market Size Growth Rate by End User
      • 1.5.2 Snake
      • 1.5.3 Spider
      • 1.5.4 Scorpion
    • 1.6 Study Objectives
    • 1.7 Years Considered
  • 2 Executive Summary
    • 2.1 Global Anti-Venom Market Size
      • 2.1.1 Global Anti-Venom Revenue 2014-2025
      • 2.1.2 Global Anti-Venom Sales 2014-2025
    • 2.2 Anti-Venom Growth Rate by Regions
      • 2.2.1 Global Anti-Venom Sales by Regions
      • 2.2.2 Global Anti-Venom Revenue by Regions
  • 3 Breakdown Data by Manufacturers
    • 3.1 Anti-Venom Sales by Manufacturers
      • 3.1.1 Anti-Venom Sales by Manufacturers
      • 3.1.2 Anti-Venom Sales Market Share by Manufacturers
      • 3.1.3 Global Anti-Venom Market Concentration Ratio (CR5 and HHI)
    • 3.2 Anti-Venom Revenue by Manufacturers
      • 3.2.1 Anti-Venom Revenue by Manufacturers (2014-2019)
      • 3.2.2 Anti-Venom Revenue Share by Manufacturers (2014-2019)
    • 3.3 Anti-Venom Price by Manufacturers
    • 3.4 Anti-Venom Manufacturing Base Distribution, Product Types
      • 3.4.1 Anti-Venom Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Anti-Venom Product Type
      • 3.4.3 Date of International Manufacturers Enter into Anti-Venom Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 4 Breakdown Data by Product
    • 4.1 Global Anti-Venom Sales by Product
    • 4.2 Global Anti-Venom Revenue by Product
    • 4.3 Anti-Venom Price by Product
  • 5 Breakdown Data by End User
    • 5.1 Overview
    • 5.2 Global Anti-Venom Breakdown Data by End User
  • 6 North America
    • 6.1 North America Anti-Venom by Countries
      • 6.1.1 North America Anti-Venom Sales by Countries
      • 6.1.2 North America Anti-Venom Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Anti-Venom by Product
    • 6.3 North America Anti-Venom by End User
  • 7 Europe
    • 7.1 Europe Anti-Venom by Countries
      • 7.1.1 Europe Anti-Venom Sales by Countries
      • 7.1.2 Europe Anti-Venom Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Anti-Venom by Product
    • 7.3 Europe Anti-Venom by End User
  • 8 Asia Pacific
    • 8.1 Asia Pacific Anti-Venom by Countries
      • 8.1.1 Asia Pacific Anti-Venom Sales by Countries
      • 8.1.2 Asia Pacific Anti-Venom Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Anti-Venom by Product
    • 8.3 Asia Pacific Anti-Venom by End User
  • 9 Central & South America
    • 9.1 Central & South America Anti-Venom by Countries
      • 9.1.1 Central & South America Anti-Venom Sales by Countries
      • 9.1.2 Central & South America Anti-Venom Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Anti-Venom by Product
    • 9.3 Central & South America Anti-Venom by End User
  • 10 Middle East and Africa
    • 10.1 Middle East and Africa Anti-Venom by Countries
      • 10.1.1 Middle East and Africa Anti-Venom Sales by Countries
      • 10.1.2 Middle East and Africa Anti-Venom Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Anti-Venom by Product
    • 10.3 Middle East and Africa Anti-Venom by End User
  • 11 Company Profiles
    • 11.1 Medtoxin Venom Laboratories
      • 11.1.1 Medtoxin Venom Laboratories Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Medtoxin Venom Laboratories Anti-Venom Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Medtoxin Venom Laboratories Anti-Venom Products Offered
      • 11.1.5 Medtoxin Venom Laboratories Recent Development
    • 11.2 Institute of Immunology
      • 11.2.1 Institute of Immunology Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Institute of Immunology Anti-Venom Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Institute of Immunology Anti-Venom Products Offered
      • 11.2.5 Institute of Immunology Recent Development
    • 11.3 Alomone Labs
      • 11.3.1 Alomone Labs Company Details
      • 11.3.2 Company Business Overview
      • 11.3.Alomone Labs Anti-Venom Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Alomone Labs Anti-Venom Products Offered
      • 11.3.5 Alomone Labs Recent Development
    • 11.4 Sigma Aldrich
      • 11.4.1 Sigma Aldrich Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Sigma Aldrich Anti-Venom Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Sigma Aldrich Anti-Venom Products Offered
      • 11.4.5 Sigma Aldrich Recent Development
    • 11.5 Wyeth Pharmaceuticals
      • 11.5.1 Wyeth Pharmaceuticals Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Wyeth Pharmaceuticals Anti-Venom Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Wyeth Pharmaceuticals Anti-Venom Products Offered
      • 11.5.5 Wyeth Pharmaceuticals Recent Development
    • 11.6 Protherics PLC
      • 11.6.1 Protherics PLC Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Protherics PLC Anti-Venom Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Protherics PLC Anti-Venom Products Offered
      • 11.6.5 Protherics PLC Recent Development
    • 11.7 Bharat Serums and Vaccines
      • 11.7.1 Bharat Serums and Vaccines Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Bharat Serums and Vaccines Anti-Venom Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Bharat Serums and Vaccines Anti-Venom Products Offered
      • 11.7.5 Bharat Serums and Vaccines Recent Development
    • 11.8 Butantan Institute
      • 11.8.1 Butantan Institute Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Butantan Institute Anti-Venom Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Butantan Institute Anti-Venom Products Offered
      • 11.8.5 Butantan Institute Recent Development
    • 11.9 Haffkine Bio-Pharmaceutical Corporation
      • 11.9.1 Haffkine Bio-Pharmaceutical Corporation Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Haffkine Bio-Pharmaceutical Corporation Anti-Venom Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Haffkine Bio-Pharmaceutical Corporation Anti-Venom Products Offered
      • 11.9.5 Haffkine Bio-Pharmaceutical Corporation Recent Development
    • 11.10 Micropaharm Limited
      • 11.10.1 Micropaharm Limited Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Micropaharm Limited Anti-Venom Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Micropaharm Limited Anti-Venom Products Offered
      • 11.10.5 Micropaharm Limited Recent Development
  • 12 Future Forecast
    • 12.1 Anti-Venom Market Forecast by Regions
      • 12.1.1 Global Anti-Venom Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Anti-Venom Revenue Forecast by Regions 2019-2025
    • 12.2 Anti-Venom Market Forecast by Product
      • 12.2.1 Global Anti-Venom Sales Forecast by Product 2019-2025
      • 12.2.2 Global Anti-Venom Revenue Forecast by Product 2019-2025
    • 12.3 Anti-Venom Market Forecast by End User
    • 12.4 North America Anti-Venom Forecast
    • 12.5 Europe Anti-Venom Forecast
    • 12.6 Asia Pacific Anti-Venom Forecast
    • 12.7 Central & South America Anti-Venom Forecast
    • 12.8 Middle East and Africa Anti-Venom Forecast
  • 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators
  • 14 Value Chain and Sales Channels Analysis
    • 14.1 Value Chain Analysis
    • 14.2 Anti-Venom Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors
  • 15 Research Findings and Conclusion
  • 16 Appendix
    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details
    • 16.3 Disclaimer

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Our Happy Customers